Gland Pharma reported a 27.74% increase in Q3 net profit to ₹261.48 crore, up from ₹204.69 crore last year. Revenue rose 22.49% YoY to ₹1695.36 crore, with EBITDA increasing 21% YoY to ₹434.9 crore.
Source :- mint – markets Read More
- Home
- Livemint Markets
Gland Pharma Q3 Results: Profit surges 28% YoY to ₹261 crore; revenue rises 22%
- No Comments
- 6 Min Read
Share it :
Get free tips and resources right in your inbox, along with 10,000+ others
Categories
Latest Post
August 21, 2026
August 21, 2026
August 20, 2026
